Department of Health Sciences, University of Florence, Florence, Italy.
School of Applied Sciences, London South Bank University, London, UK.
Clin Psychol Psychother. 2024 Jan-Feb;31(1):e2961. doi: 10.1002/cpp.2961.
Although a probable association between metacognitive beliefs (also termed 'metacognitions') and emotion dysregulation has been suggested in the literature, the evidence is still sparse and inconclusive. The current study aims to present a comprehensive evaluation of the literature examining the association between metacognitive beliefs and emotion dysregulation. In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria, a search was conducted on PubMed and Ebsco. A manual search of reference lists was also run. Search terms were 'metacognitions/metacognitive beliefs/positive metacognitive beliefs/negative metacognitive beliefs/cognitive self-consciousness/beliefs about the need to control thoughts/cognitive confidence/negative beliefs about thoughts concerning uncontrollability and danger/AND difficulties emotion regulation/emotion dysregulation'. A total of 19 studies met the inclusion criteria. In both non-clinical and clinical populations, a higher endorsement of dysfunctional metacognitive beliefs was found to be associated with emotion dysregulation and vice versa. A higher endorsement of metacognitive beliefs may be associated, either directly or via maladaptive forms of mental control (e.g., worry, rumination and suppression) to emotion dysregulation. Metacognitive beliefs could be the potential therapeutic target in clinical interventions aimed at reducing emotion regulation difficulties.
尽管文献中已经提出元认知信念(也称为“元认知”)与情绪失调之间可能存在关联,但证据仍然很少且不确定。本研究旨在全面评估文献,以检验元认知信念与情绪失调之间的关联。根据系统评价和荟萃分析的首选报告项目(PRISMA)标准,在 PubMed 和 Ebsco 上进行了搜索。还对参考文献列表进行了手动搜索。搜索词为“元认知/元认知信念/积极元认知信念/消极元认知信念/认知自我意识/控制思维的必要性信念/认知自信/关于不可控性和危险的思维的消极信念/和情绪调节困难/情绪失调”。共有 19 项研究符合纳入标准。在非临床和临床人群中,发现对功能失调的元认知信念的更高认可与情绪失调有关,反之亦然。元认知信念的更高认可可能与情绪失调直接相关,也可能通过不适应的心理控制形式(例如,担忧、沉思和抑制)间接相关。元认知信念可能是旨在减少情绪调节困难的临床干预的潜在治疗靶点。